AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Feb 6, 2024

30870_dirs_2024-02-06_04d2279b-860f-43d2-802a-1674502050ae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-02-06

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-06	Common Stock	M	28605	$6.67	Acquired	175578	Direct
2024-02-06	Common Stock	S	28605	$79.30	Disposed	146973	Direct
2024-02-06	Common Stock	S	4000	$79.28	Disposed	142973	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-06	Non-Qualified Stock Option (Right to Buy)	$6.67	M	28605	Disposed	2026-02-23	Common Stock (28605)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.